VolitionRx GC has shares canceled for tax withholding

VolitionRx Ltd (VNRX) general counsel reports tax‑withholding share cancellation.

Rhea-AI Filing Summary

VolitionRx Ltd (VNRX) general counsel reports tax‑withholding share cancellation. On February 1, 2026, officer Nicholas Plummer had 5,647 shares of common stock withheld and retained by VolitionRx for cancellation at $0.285 per share to cover tax obligations on the settlement of restricted stock units.

After this non‑market transaction, Plummer beneficially owned 233,137 shares of common stock directly. The footnote clarifies that no shares were sold by either the reporting person or VolitionRx; the shares were simply canceled to satisfy withholding taxes on equity compensation granted in lieu of cash pay.

Insider Trade Summary

Exercise Price or Tax Liability: 5,647 shares

Exercise Price or Tax Liability 1 txn

Insider Plummer Nicholas

Role GC - Volition Diagnostics

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	5,647	$0.285	$2K

Holdings After Transaction: Common Stock — 233,137 shares (Direct)

Footnotes (1)

1. F1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,015 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VolitionRx (VNRX) report for Nicholas Plummer?

VolitionRx reported that general counsel Nicholas Plummer had 5,647 common shares withheld and canceled to cover tax obligations on vested restricted stock units. This was a non-market transaction used solely for tax withholding, with no shares sold into the open market.

Was any stock actually sold in the latest VolitionRx (VNRX) Form 4?

No, the filing states no shares were sold by Nicholas Plummer or VolitionRx. Instead, 5,647 common shares were retained and canceled by the company to satisfy tax withholding on 12,015 restricted stock units that had settled as compensation.

How many VolitionRx (VNRX) shares does Nicholas Plummer hold after this transaction?

After the tax-withholding share cancellation, Nicholas Plummer beneficially owns 233,137 shares of VolitionRx common stock directly. The reported transaction only reduced shares through cancellation to cover taxes on equity compensation, rather than a discretionary sale of shares.

What does transaction code F mean in the VolitionRx (VNRX) Form 4?

Transaction code F indicates shares were withheld to pay taxes on an equity award. In this case, VolitionRx retained 5,647 shares for cancellation at $0.285 per share to satisfy Nicholas Plummer’s tax obligations on 12,015 restricted stock units that settled as compensation.

What equity award triggered the tax withholding in VolitionRx (VNRX) Form 4?

The tax withholding was triggered by settlement of 12,015 restricted stock units awarded to Nicholas Plummer. These RSUs were granted in lieu of cash compensation, and a portion of the resulting shares was canceled to cover associated tax withholding requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plummer Nicholas

(Last) (First) (Middle)

1489 WEST WARM SPRINGS ROAD

SUITE 110

(Street)

HENDERSON NV 89014

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC - Volition Diagnostics

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/01/2026		F		5,647(1)	D	$0.285	233,137	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,015 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

Remarks:

	/s/ Nicholas Plummer	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.